Emil raises Rs 150 cr from Somerset Indus Capital

Synopsis “The investment is through a mix of primary (Rs 120 crore) and secondary (Rs 30 crore) sale,” said Tushar Korday director, Emil Pharmaceutical. “The investment outlay may increase in the near future,” Korday added, but the company did not disclose the size of the minority stake. ETtech Emil Pharmaceutical Industries , the Mumbai-based privately held contract manufacturer, has sold a minority stake to raise Rs 150 crore from Somerset Indus Capital Partners .

“The investment is through a mix of primary (Rs 120 crore) and secondary (Rs 30 crore) sale,” said Tushar Korday director, Emil Pharmaceutical. “The investment outlay may increase in the near future,” Korday added, but the company did not disclose the size of the minority stake. Korday said Emil plans to utilise the proceeds for rapid expansion and modernization of pharmaceutical formulations’ capacities and increasing its footprints in rest-of-the-world (ROW) as well as regulated markets.

Emil is also gearing up to widen its product basket including expanding into nutraceuticals, along with looking at inorganic growth opportunities complementary to its business, people privy to the deal told ET. “We at Emil are indeed honoured to have such a strong group of investors backing us as we continue to innovate and grow. This funding will allow us to achieve the desired goals of the management,” Korday added.

” Zulfiqar Shivji and Viral Sharda of ZADN & Associates advised Emil Pharmaceutical in raising funds from the PE fund,” said a person who is part of the team that advised the transaction. The investment will be Somerset Indus Capital’s fifth, and second pharmaceutical investment, from its Fund II. Don’t miss out on ET Prime stories! Get your daily dose of business updates on WhatsApp.

click here! Tuesday, 25 Apr, 2023 Experience Your Economic Times Newspaper, The Digital Way! Read Complete Print Edition » Front Page Pure Politics Companies Brands & Companies More Startups Call for Exempting More from Angel Tax The startup industry is lobbying the finance ministry to scrap, or at least increase, the ₹25-crore paid-up capital threshold for exemption from the so-called angel tax. Vedanta Resources Clears Apr Dues, Cuts Debt by $1b London-based Vedanta Resources (VRL), the parent company of India-listed Vedanta Ltd (VDL), said on Monday that it had paid off loans and bonds due in April and reduced gross debt by $1 billion. Pvt Sector Capex in Focus at ET Awards Prime Minister Narendra Modi wants Indian industry to unleash its animal spirits, building on the investment thrust led by the Centre that’s seeing a vast infrastructure buildout across the country.

Read More News on somerset indus capital s fifth somerset indus capital partners emil pharmaceutical industries emil pharmaceutical zulfiqar shivji tushar korday korday zadn & associates (Catch all the Business News , Breaking News Events and Latest News Updates on The Economic Times . ) Download The Economic Times News App to get Daily Market Updates & Live Business News. .

. . more less ETPrime stories of the day Jobs No industry for freshers: techies feel the heat as IT firms go on a hire-and-fire mode 7 mins read FMCG What is contributing to Nestlé India’s market dominance? No, it’s not Maggi but Cerelac.

10 mins read Deals Q1 CY23 sees more mid-market and traditional sector M&As as overall deal activity drops. 8 mins read Subscribe to ETPrime.